Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$2.07
-0.72%
Mkt Cap $404.60M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+383.8%
Consensus $10.00 vs current $2.07
NASDAQ·Healthcare·Biotechnology
$2.07
-0.72%
Mkt Cap $404.60M
Buy
2
Hold
0
Sell
0
Price Target (9 analysts)
$10.00
Range $10.00 – $10.00
+383.8%
Consensus $10.00 vs current $2.07